Past Virtual Events

Share
VIDEO | 01:59:39
Tumor board moderated by Dr. Andrew Seidman and Dr. Jasmeet Singh.
Tumor Board on Metaplastic Breast Cancer
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) facilitates a discussion with experts from MSK and Max Healthcare (India) about the unique clinical scenarios, challenges, and global perspectives associated with metaplastic breast cancer.
Tumor board moderated by Dr. Dennis Chi, MSK and Dr. Rema P, RCC, Thiruvananthapuram
Multidisciplinary Tumor Board Mucinous Ovarian Neoplasms
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. Doctors from MSK in New York partnered with doctors from RCC, Thiruvananthapuram to present two mucinous ovarian neoplasms cases as part of an ongoing multidisciplinary tumor board series.
Tumor board moderated by Dr. Jasmeet C. Singh, MSK, New York and Dr. Andrew D. Seidman, MSK, New York of MSK and Dr. Atul Batra of AIIMS, India.
Unraveling the Challenges: Comprehensive Approach to Management of Oligoprogression in Breast Cancer
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) and Dr. Atul Batra (AIIMS, India) moderate a discussion with their fellow world-renowned colleagues about the management of oligoprogression in breast cancer.
Tumor board moderated by Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai and Dr. Mrinal Gounder of Memorial Sloan Kettering Cancer Center (MSK)
International Precision Oncology Tumor Board - Targeting the MEK Pathway
Join leading global experts to discover best practices on interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient.
Tumor board directed by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital, Mumbai.
International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
The second in an ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai, this tumor board focused on the BRAF pathway.
Tumor board moderators Dr. Jennifer Mueller of MSK and Dr. Thomas Samuel Ram of CMC Vellore
Multidisciplinary Tumor Board on Advanced/Recurrent Endometrial Cancer - MSK & CMC Vellore
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To share expertise, advance research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this particular event, we are honored to partner with CMC Vellore in India.
Tumor board moderated by Dr. Snehal Patel of MSK and Dr. Anil D'Cruz of Apollo Hospital in Delhi.
Surgical Margins in Management of Oral Cancer - MSK & Apollo
Partnering with Apollo Hospital in Mumbai, India the multidisciplinary tumor board on May 19 included presentations on margin assessment, along with case studies on management of early oral cancer as well as locally advanced oral cancer.
VIDEO | 1:57:00
Tumor board directed by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital, Mumbai.
International Precision Oncology Tumor Board Targeting the KRAS Pathway
The first in an ongoing series, this tumor board focused on the emerging and important KRAS pathway.
VIDEO | 1:29:16
Tumor board moderated by Dr. Jennifer Mueller from MSK and Dr. Nitesh Rohatgi from Fortis Healthcare.
Multidisciplinary Tumor Board on Uterine Sarcoma:  MSK and Fortis
Partnering with Fortis Healthcare in Gurugram, India, this Multidisciplinary Tumor Board on March 31, 2023 explored cases and lectures on endometrial stromal sarcoma (ESS) and uterine leiomyosarcoma (LMS).
VIDEO | 1:36:28
Dr. Moni A. Kuriakose, Head and Neck Surgeon MSCC Bangalore and Dr. Bhuvanesh Singh, Head and Neck Surgeon MSK.
Multidisciplinary Tumor Board on the Diagnosis and Management of Potentially Malignant Lesions in the Oral Cavity: MSK and MSCC
Partnering with Mazumdar Shaw Cancer Center (MSCC) in Bangalore, this Multidisciplinary Tumor Board on January 21, 2023 explored the diagnosis and management of potentially malignant lesions in the oral cavity. The tumor board was moderated by head and neck surgeons Dr. Bhuvanesh Singh from MSK and Dr. Moni A. Kuriakose from MSCC.
VIDEO | 1:29:38
Dr. Mario M. Leitao, GYN Surgeon MSK, and Dr. Sachin Khurana, Medical Oncologist, AIIMS, New Delhi.
December 9, 2022 - Multidisciplinary Tumor Board on Cervical Cancer:  MSK and AIIMS
Partnering with AIIMS in New Delhi, the Multidisciplinary Tumor Board on Cervical Cancer explored two complex cases involving recurrent endocervical adenocarcinoma and relapsed cervical carcinoma. It also featured presentations on systemic therapies and novel targets and prevention of cervical cancer in India.
VIDEO | 2:02:44
MSK Surgeon Dr. Ashok Shaha and Dr. Arvind Krishnamurthy, Surgeon From the Cancer Institute (WIA)
September 17, 2022 - Multidisciplinary Tumor Board on Complex Thyroid Cancer: MSK and CI (WIA)
In our joint tumor board on complex thyroid cancer, we explored three patient cases involving anaplastic, medullary, and recurrent differentiated thyroid cancer. Following these cases was a presentation and discussion about tracheal resections in thyroid cancer.
VIDEO | 4:08:04
Dr. Atul Batra, of AIIMS New Delhi, and Dr. Neil Iyengar, of MSK, Present Collaborative Study
August 27, 2022 - New Frontiers in Cancer Research Clinical Symposium

Memorial Sloan Kettering Cancer Center (MSK) hosted its first virtual clinical symposium in India, where we enjoyed robust presentations, question and answer sessions, and conversations with oncologists from across India. Topics included the inherent challenges and opportunities in studying cancers globally, new digital tools and pathways for managing cancer care, translational research, germline testing, and more.

VIDEO | 1:40:00
Moderators Dr. Kara Long Roche & Dr. Jayasharee Natarajan
August 5, 2022 - Multidisciplinary Tumor Board on Low Grade Ovarian Tumors: MSK and CI (WIA)
We were honored to co-host the event with the Cancer Institute (WIA), Adyar, Chennai. In this joint tumor board, we discussed two patients with serious ovarian cancer in the early and late stage. We also heard from the expert panelists on current management as well as the latest advances and ongoing research in this field.
VIDEO | 2:04:22
Moderators Dr. Jatin Shah and Dr. Krishnakumar Thankappan
July 2, 2022 - Multidisciplinary Tumor Board On Skull Base Malignancies: MSK and Amrita 
The host institution for this head and neck event on skull base malignancies was Amrita Hospital in Kochi. Two cases were discussed including: ethmoid cancer suitable for endonasal resection and locally advanced malignant tumor involving the skull base/orbit. This was followed by two lectures: Principles of Reconstructive Surgery Following Major Skull Base Resection With or Without Orbital Exenteration and 2022 Outcomes of International Collaborative Study on Skull Base Surgery.
VIDEO | 1:41:48
Moderator Dr. Jatin Shah of MSK
May 7, 2022 - Multidisciplinary Tumor Board On Salivary Cancer: MSK and HCG
This head and neck event, a joint tumor board on salivary cancer, was moderated by Dr. Richard Wong of MSK and Dr. Kaustubh Patel of HCG. Two cases involving parotid cancer were discussed, followed by lectures on parotid surgery and nuances in facial construction, and nuances in facial reanimation.
VIDEO | 45:26
tbd
March 25, 2022 - Conversation with Ms. Manisha Koirala
During our event focused on ovarian cancer, we had the distinct privilege to present a conversation between Ms. Manisha Koirala and Dr. William Breitbart about the patient perspective.